Search results
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 21 hours agoThe FDA agreed to a 212-person confirmatory Registration Study based on the strength of the safety and survival benefit data in the selected target population from the prior ...
FDA greenlights CEL-SCI confirmatory study for Multikine By Investing.com
Investing.com· 20 hours agoCEL-SCI Corporation (NYSE American: CVM) announced today that the U.S. Food and Drug Administration...
Cancer immunity gets a boost from one common nutrient, study finds: ‘Intrigue and optimism’
Fox News via Yahoo News· 1 week agoVitamin D could be a surprise weapon against cancer, new research suggests. A doctor weighed in in...
Combined therapy makes headway for liver cancer
Medical Xpress· 6 days agoThe findings, published in Nature Communications, show the potential benefits of augmenting immunotherapy for this and other forms of cancer. "This study shows the promise of improving the success ...